Prof
Prof Michelle Lockley
Oncology
About
Professor Lockley completed her undergraduate training at University College London and obtained her PhD from Queen Mary University of London. She leads a research group at Barts Cancer Institute discovering new ways to treat ovarian cancer and strategies to overcome treatment resistance. She has received several personal fellowships from the Medical Research Council (MRC) and Cancer Research UK to support this research. In addition to her laboratory-based research programme, Professor Lockley also contributes to various clinical trials.
She has a special interest in treating ovarian germ cell tumours and is Vice-Chair of the Malignant Germ Cell International Consortium (MaGIC).
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Prof Michelle Lockley
Education & training
-
2012–2018 MD · Medicine and Surgery
-
2018–2022 Residency · Oncology
-
2022–2023 Fellowship · Subspecialty training
Career & appointments
-
2022-09–2023-08 Junior consultant
Licenses & insurance
Medical licenses
Board certifications
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 233 |
| Annual physical exam | 99395 | 2,495 |
| Vaccination administration | 90471 | 2,583 |
| Minor procedure (skin) | 17110 | 352 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 60 min | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 90 min | in_clinic | 720.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 13 · i10: 9
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.3294/euroclin.2025.0 · PMID: 31590698 · cited by 121
-
European registry analysis of Oncology outcomes
DOI: 10.6384/euroclin.2024.1 · PMID: 33516273 · cited by 131
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2023
- national college of family doctors — Member · since 2023
- European Union of Medical Specialists (UEMS) — Member · since 2023
Patient reviews
- Bedside Manner
- 0.05
- Knowledge
- 0.08
- Wait Time
- 3.80
- Staff Friendliness
- 0.02
- Ease Of Appointment
- 4.00
- Value For Money
- 4.10
- Would Recommend Pct
- 4
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · michelle.lockley@euroclinics.example